Cargando…

Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient

BACKGROUND: The last decade has seen a major increase in the availability of genomic data. This includes expert-curated databases that describe the biological activity of genes, as well as high-throughput assays that measure gene expression in bulk tissue and single cells. Integrating these heteroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Harikumar, Haripriya, Quinn, Thomas P., Rana, Santu, Gupta, Sunil, Venkatesh, Svetha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340371/
https://www.ncbi.nlm.nih.gov/pubmed/34353329
http://dx.doi.org/10.1186/s13040-021-00263-w
_version_ 1783733757263478784
author Harikumar, Haripriya
Quinn, Thomas P.
Rana, Santu
Gupta, Sunil
Venkatesh, Svetha
author_facet Harikumar, Haripriya
Quinn, Thomas P.
Rana, Santu
Gupta, Sunil
Venkatesh, Svetha
author_sort Harikumar, Haripriya
collection PubMed
description BACKGROUND: The last decade has seen a major increase in the availability of genomic data. This includes expert-curated databases that describe the biological activity of genes, as well as high-throughput assays that measure gene expression in bulk tissue and single cells. Integrating these heterogeneous data sources can generate new hypotheses about biological systems. Our primary objective is to combine population-level drug-response data with patient-level single-cell expression data to predict how any gene will respond to any drug for any patient. METHODS: We take 2 approaches to benchmarking a “dual-channel” random walk with restart (RWR) for data integration. First, we evaluate how well RWR can predict known gene functions from single-cell gene co-expression networks. Second, we evaluate how well RWR can predict known drug responses from individual cell networks. We then present two exploratory applications. In the first application, we combine the Gene Ontology database with glioblastoma single cells from 5 individual patients to identify genes whose functions differ between cancers. In the second application, we combine the LINCS drug-response database with the same glioblastoma data to identify genes that may exhibit patient-specific drug responses. CONCLUSIONS: Our manuscript introduces two innovations to the integration of heterogeneous biological data. First, we use a “dual-channel” method to predict up-regulation and down-regulation separately. Second, we use individualized single-cell gene co-expression networks to make personalized predictions. These innovations let us predict gene function and drug response for individual patients. Taken together, our work shows promise that single-cell co-expression data could be combined in heterogeneous information networks to facilitate precision medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s13040-021-00263-w).
format Online
Article
Text
id pubmed-8340371
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83403712021-08-06 Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient Harikumar, Haripriya Quinn, Thomas P. Rana, Santu Gupta, Sunil Venkatesh, Svetha BioData Min Research BACKGROUND: The last decade has seen a major increase in the availability of genomic data. This includes expert-curated databases that describe the biological activity of genes, as well as high-throughput assays that measure gene expression in bulk tissue and single cells. Integrating these heterogeneous data sources can generate new hypotheses about biological systems. Our primary objective is to combine population-level drug-response data with patient-level single-cell expression data to predict how any gene will respond to any drug for any patient. METHODS: We take 2 approaches to benchmarking a “dual-channel” random walk with restart (RWR) for data integration. First, we evaluate how well RWR can predict known gene functions from single-cell gene co-expression networks. Second, we evaluate how well RWR can predict known drug responses from individual cell networks. We then present two exploratory applications. In the first application, we combine the Gene Ontology database with glioblastoma single cells from 5 individual patients to identify genes whose functions differ between cancers. In the second application, we combine the LINCS drug-response database with the same glioblastoma data to identify genes that may exhibit patient-specific drug responses. CONCLUSIONS: Our manuscript introduces two innovations to the integration of heterogeneous biological data. First, we use a “dual-channel” method to predict up-regulation and down-regulation separately. Second, we use individualized single-cell gene co-expression networks to make personalized predictions. These innovations let us predict gene function and drug response for individual patients. Taken together, our work shows promise that single-cell co-expression data could be combined in heterogeneous information networks to facilitate precision medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s13040-021-00263-w). BioMed Central 2021-08-05 /pmc/articles/PMC8340371/ /pubmed/34353329 http://dx.doi.org/10.1186/s13040-021-00263-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Harikumar, Haripriya
Quinn, Thomas P.
Rana, Santu
Gupta, Sunil
Venkatesh, Svetha
Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient
title Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient
title_full Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient
title_fullStr Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient
title_full_unstemmed Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient
title_short Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient
title_sort personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340371/
https://www.ncbi.nlm.nih.gov/pubmed/34353329
http://dx.doi.org/10.1186/s13040-021-00263-w
work_keys_str_mv AT harikumarharipriya personalizedsinglecellnetworksaframeworktopredicttheresponseofanygenetoanydrugforanypatient
AT quinnthomasp personalizedsinglecellnetworksaframeworktopredicttheresponseofanygenetoanydrugforanypatient
AT ranasantu personalizedsinglecellnetworksaframeworktopredicttheresponseofanygenetoanydrugforanypatient
AT guptasunil personalizedsinglecellnetworksaframeworktopredicttheresponseofanygenetoanydrugforanypatient
AT venkateshsvetha personalizedsinglecellnetworksaframeworktopredicttheresponseofanygenetoanydrugforanypatient